Science Translational Medicine· Maximiliano Arce, Hua Huang, Charlotte Rorsman, Iza Erzar, Joppe Oldenburg, Ying Sun, Ross Smith, Favour C. Onyeogaziri, Stefano Barbera, Frida C. Ahlstrand, Petter Ranefall, Anna Klemm, Mark Richards, Anna Dimberg, Lena Claesson-Welsh, Peetra U. Magnusson·· 14 小时前AI 评分26
激酶抑制剂达拉非尼（dabrafenib）以不依赖BRAF的方式阻止脑海绵状血管畸形进展
The kinase inhibitor dabrafenib halts progression of cerebral cavernous malformations in a BRAF-independent manner
AI 导读
激酶抑制剂达拉非尼（dabrafenib）可阻止脑海绵状血管畸形进展，其作用不依赖BRAF。所提供的Science Translational Medicine内容未列出研究设计、样本量或具体效应量。
来源：Science Translational Medicine · science.org